These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 17565587

  • 21. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hiasa Y, Kuzuhara H, Tokumoto Y, Konishi I, Yamashita N, Matsuura B, Michitaka K, Chung RT, Onji M.
    Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
    [Abstract] [Full Text] [Related]

  • 22. New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C.
    Mori K, Abe K, Dansako H, Ariumi Y, Ikeda M, Kato N.
    Biochem Biophys Res Commun; 2008 Jun 20; 371(1):104-9. PubMed ID: 18406345
    [Abstract] [Full Text] [Related]

  • 23. Epigenetic silencing of interferon-inducible genes is implicated in interferon resistance of hepatitis C virus replicon-harboring cells.
    Naka K, Abe K, Takemoto K, Dansako H, Ikeda M, Shimotohno K, Kato N.
    J Hepatol; 2006 May 20; 44(5):869-78. PubMed ID: 16545484
    [Abstract] [Full Text] [Related]

  • 24. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation.
    Helbig KJ, Ruszkiewicz A, Semendric L, Harley HA, McColl SR, Beard MR.
    Hepatology; 2004 May 20; 39(5):1220-9. PubMed ID: 15122750
    [Abstract] [Full Text] [Related]

  • 25. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
    Xu J, Liu S, Xu Y, Tien P, Gao G.
    Virus Res; 2009 Apr 20; 141(1):55-62. PubMed ID: 19185598
    [Abstract] [Full Text] [Related]

  • 26. Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo.
    Pan Q, de Ruiter PE, Metselaar HJ, Kwekkeboom J, de Jonge J, Tilanus HW, Janssen HL, van der Laan LJ.
    Hepatology; 2012 Jun 20; 55(6):1673-83. PubMed ID: 22213147
    [Abstract] [Full Text] [Related]

  • 27. CD8+ T-cell interaction with HCV replicon cells: evidence for both cytokine- and cell-mediated antiviral activity.
    Liu C, Zhu H, Tu Z, Xu YL, Nelson DR.
    Hepatology; 2003 Jun 20; 37(6):1335-42. PubMed ID: 12774012
    [Abstract] [Full Text] [Related]

  • 28. Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection.
    Sarrazin C, Mihm U, Herrmann E, Welsch C, Albrecht M, Sarrazin U, Traver S, Lengauer T, Zeuzem S.
    J Infect Dis; 2005 Nov 15; 192(10):1710-9. PubMed ID: 16235168
    [Abstract] [Full Text] [Related]

  • 29. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
    Watashi K, Hijikata M, Hosaka M, Yamaji M, Shimotohno K.
    Hepatology; 2003 Nov 15; 38(5):1282-8. PubMed ID: 14578868
    [Abstract] [Full Text] [Related]

  • 30. Oncostatin M synergistically inhibits HCV RNA replication in combination with interferon-alpha.
    Ikeda M, Mori K, Ariumi Y, Dansako H, Kato N.
    FEBS Lett; 2009 May 06; 583(9):1434-8. PubMed ID: 19332062
    [Abstract] [Full Text] [Related]

  • 31. Different anti-HCV profiles of statins and their potential for combination therapy with interferon.
    Ikeda M, Abe K, Yamada M, Dansako H, Naka K, Kato N.
    Hepatology; 2006 Jul 06; 44(1):117-25. PubMed ID: 16799963
    [Abstract] [Full Text] [Related]

  • 32. Anti-HCV activities of selective polyunsaturated fatty acids.
    Leu GZ, Lin TY, Hsu JT.
    Biochem Biophys Res Commun; 2004 May 21; 318(1):275-80. PubMed ID: 15110784
    [Abstract] [Full Text] [Related]

  • 33. Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.
    Buckwold VE, Wei J, Huang Z, Huang C, Nalca A, Wells J, Russell J, Collins B, Ptak R, Lang W, Scribner C, Blanchett D, Alessi T, Langecker P.
    Antiviral Res; 2007 Feb 21; 73(2):118-25. PubMed ID: 16987555
    [Abstract] [Full Text] [Related]

  • 34. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
    Murao K, Imachi H, Yu X, Cao WM, Nishiuchi T, Chen K, Li J, Ahmed RA, Wong NC, Ishida T.
    Gut; 2008 May 21; 57(5):664-71. PubMed ID: 17998316
    [Abstract] [Full Text] [Related]

  • 35. Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha.
    Tanabe Y, Sakamoto N, Enomoto N, Kurosaki M, Ueda E, Maekawa S, Yamashiro T, Nakagawa M, Chen CH, Kanazawa N, Kakinuma S, Watanabe M.
    J Infect Dis; 2004 Apr 01; 189(7):1129-39. PubMed ID: 15031779
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Inhibitory effects of Pycnogenol® on hepatitis C virus replication.
    Ezzikouri S, Nishimura T, Kohara M, Benjelloun S, Kino Y, Inoue K, Matsumori A, Tsukiyama-Kohara K.
    Antiviral Res; 2015 Jan 01; 113():93-102. PubMed ID: 25446333
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Mitochondrial electron transport inhibition in full genomic hepatitis C virus replicon cells is restored by reducing viral replication.
    Ando M, Korenaga M, Hino K, Ikeda M, Kato N, Nishina S, Hidaka I, Sakaida I.
    Liver Int; 2008 Sep 01; 28(8):1158-66. PubMed ID: 18410284
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.